1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > China Haematology Market Outlook to 2021

China Haematology Market Outlook to 2021

  • August 2015
  • -
  • Global Data
  • -
  • 47 pages

China Haematology Market Outlook to 2021

Summary

GlobalData’s new report, "China Haematology Market Outlook to 2021", provides key market data on the China Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Haematology market.
- Global corporate-level profiles of key companies operating within the China Haematology market.
- Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

China Haematology Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Haematology Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Haematology Market, China 9
3.1 Haematology Market, China, Revenue ($m), 2007-2014 9
3.2 Haematology Market, China, Revenue ($m), 2014-2021 11
3.2.1 Haematology Cell Counters Market, China, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Haematology Rapid Tests and POC Market, China, Revenue ($m), by Segment, 2007-2014 15
3.2.3 Haematology Reagents Market, China, Revenue ($m), by Segment, 2007-2014 17
3.2.4 Haemostasis Market, China, Revenue ($m), by Segment, 2007-2014 19
3.2.5 Immunohaematology Market, China, Revenue ($m), by Segment, 2007-2014 21
3.2.6 Haematology Cell Counters Market, China, Revenue ($m), by Segment, 2014-2021 23
3.2.7 Haematology Rapid Tests and POC Market, China, Revenue ($m), by Segment, 2014-2021 25
3.2.8 Haematology Reagents Market, China, Revenue ($m), by Segment, 2014-2021 27
3.2.9 Haemostasis Market, China, Revenue ($m), by Segment, 2014-2021 29
3.2.10 Immunohaematology Market, China, Revenue ($m), by Segment, 2014-2021 31
3.3 Haematology Market, China, Distribution Share by Revenue ($m), 2013-2014 33
3.4 Haematology Market, China, Company Share by Revenue ($m), 2014 34
4 Overview of Key Companies in China, Haematology Market 36
4.1 Sysmex Corporation 36
4.1.1 Company Overview 36
4.2 Siemens Healthcare 36
4.2.1 Company Overview 36
4.3 Mindray Medical International Limited 36
4.3.1 Company Overview 36
4.4 Nihon Kohden Corporation 37
4.4.1 Company Overview 37
4.5 Danaher Corporation 37
4.5.1 Company Overview 37
4.6 F. Hoffmann-La Roche Ltd. 37
4.6.1 Company Overview 37
4.7 Horiba, Ltd. 38
4.7.1 Company Overview 38
4.8 bioMerieux S.A. 38
4.8.1 Company Overview 38
4.9 Abbott Laboratories 38
4.9.1 Company Overview 38
5 Haematology Market Pipeline Products 39
6 Financial Deals Landscape 40
6.1 Partnerships 40
6.1.1 NoemaLife Enters into Distribution Agreement with Horiba Medical 40
7 Recent Developments 41
7.1 Financial Announcements 41
7.1.1 Oct 10, 2014: Edan Introduces Acclarix Compact Ultrasound System at ANESTHESIOLOGY2014 41
8 Appendix 44
8.1 Research Methodology 45
8.1.1 Coverage 45
8.1.2 Secondary Research 45
8.1.3 Primary Research 46
8.1.4 Company Share Analysis 46
8.1.5 Distribution Share Analysis 46
8.2 GlobalData Consulting 46
8.3 Contact Us 47
8.4 Disclaimer 47

1.1 List of Tables
Table 1: Haematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 10
Table 2: Haematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 12
Table 3: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 14
Table 4: Haematology Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 16
Table 5: Haematology Reagents Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 18
Table 6: Haemostasis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 20
Table 7: Immunohaematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 22
Table 8: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 24
Table 9: Haematology Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 26
Table 10: Haematology Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 28
Table 11: Haemostasis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 30
Table 12: Immunohaematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 32
Table 13: Haematology Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014 33
Table 14: Haematology Market, China, Company Share by Revenue ($m), USD Constant, 2014 35
Table 15: Haematology Market Pipeline Products 39
Table 16: NoemaLife Enters into Distribution Agreement with Horiba Medical 40

1.2 List of Figures
Figure 1: Haematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 9
Figure 2: Haematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Figure 3: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 13
Figure 4: Haematology Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 15
Figure 5: Haematology Reagents Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 17
Figure 6: Haemostasis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 19
Figure 7: Immunohaematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 21
Figure 8: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Figure 9: Haematology Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 25
Figure 10: Haematology Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 27
Figure 11: Haemostasis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 29
Figure 12: Immunohaematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 31
Figure 13: Haematology Market, China, Company Share (%) 2014 34

Companies Mentioned
Sysmex Corporation
Siemens Healthcare
Mindray Medical International Limited
Nihon Kohden Corporation
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Horiba, Ltd.
bioMerieux S.A.
Abbott Laboratories

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.